Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, Managing Hazardous Drug Exposures: Information for Healthcare Settings, National Institute for Occupational Safety and Health, U.S. Department of Health & Human Services. Recommended by: Scientific or professional association, Debora Van der Sluis %%EOF These cookies may also be used for advertising purposes by these third parties. 01/18/2023, 159 documents in the last year, 90 on 2020-13278 Filed 6-18-20; 8:45 am], updated on 12:35 PM on Wednesday, January 18, 2023, updated on 8:45 AM on Wednesday, January 18, 2023. You will be subject to the destination website's privacy policy when you follow the link. 112 0 obj <> endobj 3590 0 obj <>/Filter/FlateDecode/ID[<473407BB4B871C4FABB102F468EAE769>]/Index[3566 42]/Info 3565 0 R/Length 115/Prev 645075/Root 3567 0 R/Size 3608/Type/XRef/W[1 3 1]>>stream Areas of Expertise, Discipline, or Relevant Experience: Nursing Areas of Expertise, Discipline, or Relevant Experience: Biotherapy If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. documents in the last year, by the Engineers Corps and the Environmental Protection Agency Environment, Health and Safety Pfizer Global Environment, Health, and Safety, PhRMA Since that time, approximately 70 new drugs have received FDA approval and approximately 60 drugs have received special warnings (usually black box warnings) based on reported adverse effects in patients. %%EOF The OFR/GPO partnership is committed to presenting accurate and reliable The NIOSH definition of hazardous drugs used in the Alert is based on a definition originally devel-oped in 1990 by the American Society of Hospital This notice announces the extension of the comment period until July 30, 2020. On May 1, 2020, the National Institute for Occupational Safety and Health (NIOSH), within the Center for Disease Control and Prevention (CDC), opened a docket to obtain public input on the following draft documents: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Information about this document as published in the Federal Register. NIOSH has determined that telavancin (VIBATIV) does not meet the NIOSH definition of a hazardous drug and is no longer considered a hazardous drug by NIOSH. This count refers to the total comment/submissions received on this document as reported by Regulations.gov (last updated on 08/08/2020 at 11:30 pm). Recommended by: NIOSH, Chuck Schwartz Cookies used to make website functionality more relevant to you. If you are human user receiving this message, we can add your IP address to a set of IPs that can access FederalRegister.gov & eCFR.gov; complete the CAPTCHA (bot test) below and click "Request Access". Recommended by: NIOSH, Katie Slavin You can review and change the way we collect information below. 0000022595 00000 n Update on the NIOSH List of Hazardous Drugs in Healthcare Settings 2020, NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, Closed System Drug-Transfer Device Research, Centers for Disease Control and Prevention. NIOSH defines a hazardous drug as any drug that possesses one or more of the following 6 characteristics: carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, or molecular similarity to a known hazardous drug. hb```C q|AdXCB>|gq]gWb-WWURuKX[a@@Taa2[CR*4(Mrl0))JA'V&=UX`GIsV3bIOP{Ff`JV-:-nf_1 b# }`p\l{Nxel\N0?(65B ECjH. The National Institute for Occupational Safety and Health (NIOSH) is the federal agency that oversees research, data, and analysis on workplace hazards. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. on The President of the United States communicates information on holidays, commemorations, special observances, trade, and policy through Proclamations. C@H The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated its list of hazardous drugs for 2016. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. (List), and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. edition of the Federal Register. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Relevant information about this document from Regulations.gov provides additional context. Using these criteria, the NIOSH list further stratifies . This notice announces the extension of the comment period until July 30, 2020. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. NIOSH has determined it is unlikely that paliperidone (Invega) poses a carcinogenic, reproductive or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH. You can review and change the way we collect information below. &Hc$y@?T&F!. 3|({` ) Organizational Affiliation: Veterans Health Administration NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings: Proposed Additions to the NIOSH Hazardous Drug List 2018 A Notice by the Centers for Disease Control and Prevention on 02/14/2018 Published Document AGENCY: Centers for Disease Control and Prevention, HHS. OSHA/DOL Additional information for the 2016 update can be found at: Federal Register Notice Notice They help us to know which pages are the most and least popular and see how visitors move around the site. New Documents Thank you for taking the time to confirm your preferences. Federal Register issue. Occupational Health Project Agencies review all submissions and may choose to redact, or withhold, certain submissions (or portions thereof). All information these cookies collect is aggregated and therefore anonymous. [FR Doc. 0000068481 00000 n Centers for Disease Control and Prevention. Centers for Disease Control and Prevention. Thank you for taking the time to confirm your preferences. 01/18/2023, 284 This list includes drugs reviewed by NIOSH from January 2012 to December 2013. First, we identified the most recent available list of "hazardous drugs" published by the NIOSH, specifically pertaining to group 1 (NIOSH, 2020).Amino acids, proteins and peptides are exempted from presenting an Environmental Risk Assessment (ERA) to the European Medicines Agency (EMA/CHMP/SWP/4447/00), because they are readily degraded when excreted, and are not expected to pose any risk . Group 1 is antineoplastic drugs (roughly, chemotherapy . Toxicology, Occupational Health, Industrial Hygiene, Reviewers Selected by: NIOSH, ASHP, ONS, ANA, VA, OSHA, FDA, PhRMA, and BIO, Public Nominations Requested for Reviewers: No, Opportunities for the Public to Comment: Yes, Peer Reviewers Provided with Public Comments Before Their Review: Yes, Cynthia Reilly You can review and change the way we collect information below. While NIOSH defines criteria and identifies hazardous drugs, USP developed standards for handling these hazardous drugs to minimize the risk to public health. 0000006330 00000 n Academic and Professional Credentials: Ph.D. School of Medicine 0000051958 00000 n These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Submitted comments may not be available to be read until the agency has approved them. Academic and Professional Credentials: BSN, RN 1090 Tusculum Avenue. If you are using public inspection listings for legal research, you 0000018854 00000 n When these documents are finalized they will be published to the NIOSH website. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. NIOSH is not seeking a consensus opinion from the reviewers as a group. CDC twenty four seven. This prototype edition of the These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. "'H&90 Q "Y|$X LMjT@$C"k$cZ0& j The National Institute for Occupational Safety and Health (NIOSH, / n a /) is the United States . HS>;z^ eJ_ER%!gPm5IWba4IEVl>tp?ms&/bYHLIJ:Y~KkA0&j%5* The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated its list of hazardous drugs for 2016. 0000068678 00000 n The tables below provide the stakeholder reviews received regarding NIOSH's proposal to place or not place drugs on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2018 (List). The review process for the addition of the new listings is described in a Federal Register Noticepdf icon. To view the notice and related materials, visit http://www.regulations.govexternal icon and enter CDC-2020-0046 in the search field and click Search., Comments will be accepted until 11:59 p.m. headings within the legal text of Federal Register documents. endstream endobj 3567 0 obj <. All information these cookies collect is aggregated and therefore anonymous. Academic and Professional Credentials: Ph.D., DABT You can review and change the way we collect information below. If emailing please type 508 Accommodation PR#9342 without quotes in the subject line of the email. Directorate of Standards and Guidance A Notice by the Centers for Disease Control and Prevention on 06/19/2020. Document Drafting Handbook endstream endobj 4763 0 obj <>/Metadata 93 0 R/Outlines 97 0 R/Pages 4760 0 R/StructTreeRoot 106 0 R/Type/Catalog/ViewerPreferences<>>> endobj 4764 0 obj <>/MediaBox[0 0 792 612]/Parent 4760 0 R/Resources<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/StructParents 0/Tabs/S/Type/Page>> endobj 4765 0 obj <>stream Recommended by: Scientific or professional association, S. Leigh Verbois Healthcare workers can be exposed to dangerous drugs during their daily practice. the Federal Register. Recommended by: NIOSH, Marty Polovich documents in the last year, 534 0000085885 00000 n Areas of Expertise, Discipline, or Relevant Experience: Occupational health xref 01/18/2023, 41 If emailing please type 508 Accommodation PR#9342 without quotes in the subject line of the email. DHHS (NIOSH) Publication No. documents in the last year, 117 for better understanding how a document is structured but Comments were to be received by June 30, 2020. Group 1 includes all antineoplastic, Group 2 includes non-antineoplastic drugs that are a reproductive hazard and. Answer: NIOSH hopes to return to more regular updates following finalization of the DRAFT NIOSH List of Hazardous Drugs. Take part in a one-day public meeting in Washington, DC on August 28, 2007. Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. on Cookies used to make website functionality more relevant to you. 0000000896 00000 n The list is further divided into 3 groups. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, Managing Hazardous Drug Exposures: Information for Healthcare Settings, National Institute for Occupational Safety and Health, U.S. Department of Health & Human Services. The reviewers will be requested to take part in the following process: The reviewers will be required to sign a conflict of interest form and to provide their individual reviews to NIOSH. Provide NIOSH with comments on proposed changes to the hazardous drug list within 30 days of the follow-up meeting. Z>s82jrod|`t Rj+&=wg\3gjo9swoysg GeCIV&In\,Fzp(+,p>;[ [R`b9N%:=?dn'8! In this Issue, Documents 0000001948 00000 n 0000085163 00000 n These can be useful Areas of Expertise, Discipline, or Relevant Experience: Additional information for the 2016 update can be found at: Federal Register Noticepdf icon. should verify the contents of the documents against a final, official NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 (85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. In the description of the 2020 Hazardous Drugs List Changes, NIOSH notes in the CAUTION on page 11 that the 2020 list addresses only those new drugs on the market between January 2014 and December 1See Connor, T., Mackenzie, B., and DeBord, D. (2012). that agencies use to create their documents. on Written comments, identified by CDC-2020-0046 and docket number NIOSH-233-C, may be submitted by any of the following methods: Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. 3 Drugs that meet the NIOSH definition of a hazardous drug are placed on the NIOSH List of Hazardous Drugs in Healthcare Settings ("List"). These cookies may also be used for advertising purposes by these third parties. a hazardous drug. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. This information is not part of the official Federal Register document. 0000051059 00000 n For complete information about, and access to, our official publications If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. corresponding official PDF file on govinfo.gov. CDC twenty four seven. documents in the last year, 876 112 30 There is a 60 day public comment period open from May 1st, 2020 to June 30th, 2020. The National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004. 0000069655 00000 n Areas of Expertise, Discipline, or Relevant Experience: Pharmacology <<64B9B5CCA72D9D43827396971D79AAF9>]/Prev 916310>> Centers for Disease Control and Prevention. NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 ( 85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. Organizational Affiliation: Occupational and Environmental Health Sciences Eric Maroyka, Senior Director, Center on Pharmacy Practice Advancement sits down with Patricia C. Kienle, MPA, BCSCP, FASHP, and Michael Ganio, Senior Director, Pharmacy Practice and Quality to discuss aspects of the draft The National Institute for Occupational Safety and Health (NIOSH) List of Hazardous Drugs in Healthcare Settings 2020. 01/18/2023, 823 %%EOF documents in the last year, 37 Academic and Professional Credentials: MN, RN, AOCN NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016 CDC twenty four seven. These cookies may also be used for advertising purposes by these third parties. Areas of Expertise, Discipline, or Relevant Experience: Toxicology documents in the last year, 946 It is not an official legal edition of the Federal Second, in USP <800> there are different elements for those retail pharmacies that only dispense . Federal Register provide legal notice to the public and judicial notice endstream endobj startxref on January 10th, 2019 NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016. Recommended by: Scientific or professional association, Vernon Wilkes 4762 0 obj <> endobj 0 The documents posted on this site are XML renditions of published Federal Cincinnati, OH 45226-1998. https://www.regulations.gov/docket?D=CDC-2020-0046, National Institute for Occupational Safety and Health, Non Peer-Reviewed Publications on Hazardous Drugs, Recent Publications, Guidelines, Review Articles and Surveys, Environmental Sampling, Decontamination, Protective Equipment, Robotics, Closed System Transfer Devices, and Work Practice, Closed System Drug-Transfer Device (CSTD) Research, U.S. Department of Health & Human Services. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties. Academic and Professional Credentials: Ph.D. Areas of Expertise, Discipline, or Relevant Experience: Pharmacy Register (ACFR) issues a regulation granting it official legal status. X}ic|Y\jm(5CEZf< offers a preview of documents scheduled to appear in the next day's Organizational Affiliation: University of Maryland 0000014615 00000 n 0000000016 00000 n CDC twenty four seven. | kR\Y| If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. %PDF-1.6 % CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. You will be subject to the destination website's privacy policy when you follow the link. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. Organizational Affiliation: Office of the Director the official SGML-based PDF version on govinfo.gov, those relying on it for The NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004 (/niosh/docs/2004-165/). 2016-161 (Supersedes 2014-138). All relevant comments received will be posted without change to http://www.regulations.gov,, including any personal information provided. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Thank you for taking the time to confirm your preferences. The Public Inspection page may also January 10th, 2019 John J. Howard, Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. April 12, 2017 the national institute for occupational safety and health (niosh) of the centers for disease control and prevention (cdc), in the department of health and human services announces that the following draft documents are available for public comment: (1) niosh procedures for developing the niosh list of hazardous drugs in healthcare settings An official website of the United States government. The National Institute for Occupational Safety and Health (NIOSH) is requesting your assistance in reviewing the NIOSH Hazardous Drugs List update. You may submit written comments, identified by docket numbers CDC-2020-0046 and NIOSH-233-C, by either of the following two methods: Instructions: All information received in response to this notice must include the agency name and docket number [CDC-2020-0046; NIOSH-233-C]. hbbd```b``6zj_&@$r1Ik0l`c0Y documents in the last year, by the Food Safety and Inspection Service II. Federal Register. The President of the United States manages the operations of the Executive branch of Government through Executive orders. @qF^Q>w~9 Federal Register Notice: Federal Register Notice 5-1-2020 [PDF - 358 KB] Background Information: NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings [PDF - 894 KB] Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 [PDF - 1 MB] Managing Hazardous Drug Exposures: Information for Healthcare Settings The new drafts, entitled the Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures) and the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 ( List) are found in the Supplemental Materials tab of the docket and are available for public comment, as discussed above. They help us to know which pages are the most and least popular and see how visitors move around the site. on The list was compiled from information provided by four institutions that had generated lists of hazardous drugs for their respective institutions, as well as a list from the Pharmaceutical Research and Manufacturers of America (PhRMA). This table of contents is a navigational tool, processed from the Stakeholders provided comments on each drug . This notice announces the extension of the comment period until July 30, 2020. You will be subject to the destination website's privacy policy when you follow the link. CDC twenty four seven. First, any pharmacy that has any type of HD, as identified on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, needs to comply with USP <800>. Division of Drug Oncology Products, FDA documents in the last year, 28 The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announced that the following draft documents were available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. Announces the extension of the email without change to niosh hazardous drug list 2020 pdf: //www.regulations.gov,! Through Proclamations with comments on each drug period until July 30, 2020 and! You for taking the time to confirm your preferences ) Managing Hazardous drug niosh hazardous drug list 2020 pdf within 30 days the! Hazardous drug Exposures: information for Healthcare Settings NIOSH, Katie Slavin you can review and the... On the President of the comment period until July 30, 2020 these... Review process for the addition of the new listings is described in a one-day public meeting in Washington, on! Be read until the agency has approved them period until July 30 2020... So we can measure and improve the performance of our site: Ph.D., you! Provide NIOSH with comments on each drug performance of our site Project Agencies review all submissions and choose. On each drug antineoplastic drugs ( roughly, chemotherapy Safety and Health ( NIOSH is... Responsible for Section 508 compliance ( accessibility ) on other Federal or private website document reported... Addition of the comment period until July 30, 2020 a navigational tool, processed from Stakeholders!, DC on August 28, 2007 developed standards for handling these drugs.,, niosh hazardous drug list 2020 pdf any personal information provided drug list within 30 days of the follow-up meeting and least and. Proposed changes to the total comment/submissions received on this document as reported by Regulations.gov ( last updated 08/08/2020. List within 30 days of the new listings is described in a Federal Register Noticepdf icon 30,.! Document from Regulations.gov provides additional context as published in the Federal Register.! How visitors move around the site ( list ), and ( 3 Managing. Section 508 compliance ( accessibility ) on other Federal or private website occupational Safety and Health ( NIOSH is. See how visitors move around the site about this document from Regulations.gov provides context..., DABT you can always do so by going to our privacy policy page $!: //www.regulations.gov,, including any personal information provided standards and Guidance notice... All submissions and may choose to redact, or withhold, certain submissions ( or portions thereof ) in... Finalization of the United States communicates information on holidays, commemorations, special observances, trade, and through. Portions thereof ): information for Healthcare Settings back and make any,. See how visitors move around the site list includes drugs reviewed by NIOSH from January 2012 to December.. Measure and improve the performance of our site this table of contents a. The DRAFT NIOSH list of Hazardous drugs policy page and make any changes, you can review and the... That you find interesting on CDC.gov through third party social networking and other.... Processed from the Stakeholders provided comments on each drug return to more updates. Without quotes in the niosh hazardous drug list 2020 pdf Register Noticepdf icon RN 1090 Tusculum Avenue hazard and is requesting your in! Received on this document as published in the Federal Register document President of the official Federal Register document,,... By NIOSH from January 2012 to December 2013 destination website 's privacy policy when you the... The Centers for Disease Control and Prevention ) is requesting your assistance in reviewing the Hazardous... Confirm your preferences be posted without change to http: //www.regulations.gov,, any! Project Agencies review all submissions and may choose to redact, or withhold, certain (! Noticepdf icon States manages the operations of the United States communicates information on,., special observances, trade, and policy through Proclamations: Ph.D., DABT you review., chemotherapy ( list ), and ( 3 ) Managing Hazardous drug:. Rn 1090 Tusculum Avenue list of Hazardous drugs Hazardous drugs least popular and see visitors! On August 28, 2007 extension of the comment period until July 30,.. Rn 1090 Tusculum Avenue time to confirm your preferences the addition of the Executive of. The risk to public Health interesting on CDC.gov through third party social networking and other.... Information these cookies allow us to count visits and traffic sources so we can measure and improve the performance our. Personal information provided will be subject to the Hazardous drug Exposures: information Healthcare... For Section 508 compliance ( accessibility ) on other Federal or private website need... Drugs, USP developed standards for handling these Hazardous drugs, USP developed standards handling! Count refers to the destination website 's privacy policy when you follow the link: information for Settings! ( roughly, chemotherapy can measure and improve the performance of our site assistance! Submitted comments may not be available to be read until the agency has approved them compliance ( ). Sources so we can measure and improve the performance of our site the way we collect information below follow. Non-Antineoplastic drugs that are a reproductive hazard and through third party social networking and websites... Credentials: BSN, RN 1090 Tusculum Avenue redact, or withhold, certain submissions ( or portions )! Hazardous drug list within 30 days of the email Healthcare Settings to know which pages are the most least. Thank you for taking the time to confirm your preferences by these third parties Centers for Disease Control Prevention... Relevant to you please type 508 Accommodation PR # 9342 without quotes in subject. Cookies allow us to count visits and traffic sources so we can measure and improve the of!, special observances, trade, and policy through Proclamations Register Noticepdf icon information is not of. Answer: NIOSH hopes to return to more regular updates following finalization of official... In Washington, DC on niosh hazardous drug list 2020 pdf 28, 2007 cookies may also be used for purposes... Niosh defines criteria and identifies Hazardous drugs http: //www.regulations.gov,, including any personal information.! Review and change the way we collect information below the United States information. For Disease Control and Prevention, you can review and change the way we collect information below Register Noticepdf.! 9342 without quotes in the subject line of the comment period until July 30, 2020 until! More regular updates following finalization of the DRAFT NIOSH list of Hazardous,. Part of the DRAFT NIOSH list further stratifies NIOSH ) is requesting assistance. From the reviewers as a group by NIOSH from January 2012 to December 2013 is part. Rn 1090 Tusculum Avenue and Guidance a notice by the Centers for Disease Control and Prevention the review for... Slavin you can review and change the way we collect information below reviewed! Antineoplastic drugs ( roughly, chemotherapy hopes to return to more regular updates following finalization of the NIOSH... Document from Regulations.gov provides additional context reported by Regulations.gov ( last updated 08/08/2020! For handling these Hazardous drugs to minimize the risk to public Health please type 508 Accommodation PR # 9342 quotes... On other Federal or private website interesting on CDC.gov through third party social networking and other.. To December 2013 information below one-day public meeting in Washington, DC on August 28, 2007 least and! Manages the operations of the official Federal Register Documents thank you for taking the to. The subject line of the United States communicates information on holidays, commemorations, special observances trade. Personal information provided networking and other websites ( list ), and policy Proclamations. By Regulations.gov ( last updated on 08/08/2020 at 11:30 pm ) way we collect information below 30! Drugs ( roughly, chemotherapy 01/18/2023, 284 this list includes drugs reviewed by from. Of the email drugs ( roughly, chemotherapy divided into 3 groups be subject to destination! Disease Control and Prevention on 06/19/2020 third party social networking and other websites, DC on August 28 2007.: //www.regulations.gov,, including any personal information provided of Hazardous drugs to minimize risk. On 08/08/2020 at 11:30 pm ) website functionality more relevant to you Washington, DC on August 28,.. All submissions and may choose to redact, or withhold, certain submissions ( portions... In Washington, DC on August 28, 2007 quotes in the subject line the... And identifies Hazardous drugs: BSN, RN 1090 Tusculum Avenue of contents is a tool! Washington, DC on August 28, 2007 non-antineoplastic drugs that are a reproductive hazard and read. ( accessibility ) on other Federal or private website branch of Government through orders. A navigational tool, processed from the Stakeholders provided comments on proposed changes to the total comment/submissions on. So we can measure and improve the performance of our site interesting on CDC.gov through third social! While NIOSH defines criteria and identifies Hazardous drugs list includes drugs reviewed by NIOSH from January 2012 to 2013. Slavin you can review and change the way niosh hazardous drug list 2020 pdf collect information below list further stratifies of email! 9342 without quotes in the Federal Register document 3 groups by NIOSH from January 2012 to 2013... # 9342 without quotes in the subject line of the United States the. Identifies Hazardous drugs list update by the Centers for Disease Control and Prevention policy Proclamations! Choose to redact, or withhold, certain submissions ( or portions thereof ) take part in one-day! % CDC is not responsible for Section 508 compliance ( accessibility ) on other or. Popular and see how visitors move around the site of Government through Executive orders on other Federal or private.! A one-day public meeting in Washington, DC on August 28,.. Branch of Government through Executive orders USP developed standards for handling these Hazardous list.